The latest research shows that natriuretic peptide receptor 1 (NPR1) promotes gastric cancer metastasis by activating lipolysis and enhancing fatty acid-driven oxidative phosphorylation (OXPHOS), while NPR1 silencing suppresses metastasis, highlighting it as a potential lipid metabolism-targeted therapy [106]. This evidence concerns the gene NPR1 and gastric cancer.